ScoreWhy is Astrazeneca Pharma India Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 15.14% of over the last 5 years
2
Flat results in Jun 26
- PBT LESS OI(Q) At Rs 41.76 cr has Fallen at -27.0% (vs previous 4Q average)
- PAT(Q) At Rs 38.11 cr has Fallen at -20.4% (vs previous 4Q average)
- OPERATING CF(Y) Lowest at Rs -15.14 Cr
3
With ROE of 21.9, it has a Very Expensive valuation with a 23.5 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -8.05%, its profits have fallen by -5.3%
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 5.40% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -8.05% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Astrazeneca Phar for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Astrazeneca Phar
-7.91%
-0.35
22.71%
Sensex
-1.65%
-0.12
13.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
22.84%
EBIT Growth (5y)
15.14%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
1.88
Tax Ratio
25.65%
Dividend Payout Ratio
47.99%
Pledged Shares
0
Institutional Holding
8.76%
ROCE (avg)
97.56%
ROE (avg)
20.64%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
107
Industry P/E
37
Price to Book Value
23.49
EV to EBIT
85.90
EV to EBITDA
76.53
EV to Capital Employed
47.28
EV to Sales
8.81
PEG Ratio
NA
Dividend Yield
0.44%
ROCE (Latest)
64.54%
ROE (Latest)
21.94%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
DPS(Y)
Highest at Rs 36.00
NET SALES(Q)
Highest at Rs 682.79 cr
-13What is not working for the Company
PBT LESS OI(Q)
At Rs 41.76 cr has Fallen at -27.0% (vs previous 4Q average
PAT(Q)
At Rs 38.11 cr has Fallen at -20.4% (vs previous 4Q average
OPERATING CF(Y)
Lowest at Rs -15.14 Cr
OPERATING PROFIT TO NET SALES (Q)
Lowest at 7.17%
Loading Valuation Snapshot...
Here's what is working for Astrazeneca Phar
Dividend per Share (DPS) - Annually
Highest at Rs 36.00 and Grown
each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (Rs)
Net Sales - Quarterly
Highest at Rs 682.79 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 682.79 cr has Grown at 20.0% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 568.90 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Astrazeneca Phar
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 41.76 cr has Fallen at -27.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 57.24 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 38.11 cr has Fallen at -20.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 47.88 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Cash Flow - Annually
Lowest at Rs -15.14 Cr
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 7.17%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
